Free Trial

Option Care Health, Inc. (NASDAQ:OPCH) Shares Bought by Dimensional Fund Advisors LP

→ Exposed: 3 CENT Crypto to Explode June 24th? (From True Market Insiders) (Ad)
Option Care Health logo with Medical background

Dimensional Fund Advisors LP lifted its stake in shares of Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 8.8% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 3,191,672 shares of the company's stock after purchasing an additional 258,933 shares during the quarter. Dimensional Fund Advisors LP owned about 1.80% of Option Care Health worth $107,530,000 at the end of the most recent quarter.

Several other hedge funds also recently made changes to their positions in OPCH. Vanguard Group Inc. boosted its position in shares of Option Care Health by 11.8% in the third quarter. Vanguard Group Inc. now owns 19,319,352 shares of the company's stock worth $624,981,000 after acquiring an additional 2,037,162 shares during the last quarter. Third Point LLC increased its holdings in shares of Option Care Health by 55.7% in the 3rd quarter. Third Point LLC now owns 5,450,659 shares of the company's stock valued at $176,329,000 after acquiring an additional 1,950,659 shares during the last quarter. Assenagon Asset Management S.A. bought a new stake in shares of Option Care Health in the 3rd quarter valued at approximately $36,239,000. Fiera Capital Corp acquired a new stake in shares of Option Care Health during the third quarter worth $21,370,000. Finally, Riverbridge Partners LLC lifted its holdings in shares of Option Care Health by 49.5% in the 4th quarter. Riverbridge Partners LLC now owns 1,792,012 shares of the company's stock worth $60,373,000 after purchasing an additional 593,706 shares during the last quarter. Institutional investors and hedge funds own 98.05% of the company's stock.

Wall Street Analysts Forecast Growth

Several research analysts have recently issued reports on the company. Barrington Research reissued an "outperform" rating and issued a $38.00 price target on shares of Option Care Health in a research note on Wednesday, April 24th. Jefferies Financial Group boosted their price objective on Option Care Health from $36.00 to $38.00 and gave the stock a "buy" rating in a report on Monday, March 4th.


Check Out Our Latest Research Report on OPCH

Insider Activity

In other news, Director Harry M. Jansen Kraemer, Jr. purchased 35,000 shares of Option Care Health stock in a transaction on Monday, February 26th. The stock was purchased at an average price of $31.55 per share, with a total value of $1,104,250.00. Following the transaction, the director now directly owns 269,528 shares in the company, valued at approximately $8,503,608.40. The acquisition was disclosed in a legal filing with the SEC, which is available at the SEC website. 0.64% of the stock is currently owned by company insiders.

Option Care Health Price Performance

Shares of NASDAQ:OPCH traded down $0.10 during midday trading on Wednesday, reaching $29.03. 960,428 shares of the company's stock were exchanged, compared to its average volume of 1,306,578. The firm has a market capitalization of $5.05 billion, a PE ratio of 19.10, a price-to-earnings-growth ratio of 1.41 and a beta of 1.26. The company's 50 day simple moving average is $30.99 and its two-hundred day simple moving average is $31.43. Option Care Health, Inc. has a 12 month low of $26.17 and a 12 month high of $35.74. The company has a debt-to-equity ratio of 0.74, a quick ratio of 1.39 and a current ratio of 1.77.

Option Care Health (NASDAQ:OPCH - Get Free Report) last issued its quarterly earnings data on Tuesday, April 23rd. The company reported $0.26 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.22 by $0.04. The firm had revenue of $1.15 billion during the quarter, compared to the consensus estimate of $1.10 billion. Option Care Health had a return on equity of 18.92% and a net margin of 6.15%. The business's revenue for the quarter was up 12.8% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.21 EPS. Equities research analysts expect that Option Care Health, Inc. will post 1.19 earnings per share for the current fiscal year.

Option Care Health Profile

(Free Report)

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.

Read More

Institutional Ownership by Quarter for Option Care Health (NASDAQ:OPCH)

Should you invest $1,000 in Option Care Health right now?

Before you consider Option Care Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Option Care Health wasn't on the list.

While Option Care Health currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Energy Stocks to Buy and Hold Forever Cover

Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Will FOMC Push Stocks Higher? Here’s What to Expect
Unlock Growth: Understanding Dividend Yield
Palantir Stock Excluded from S&P 500: Still a Buy?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines